Uric acid-lowering drugs include drugs that promote uric acid excretion, such as benzbromarone and probenecid; drugs that inhibit uric acid synthesis, such as allopurinol and febuxostat; and new types of uric acid-lowering drugs, such as labrylase. Uric acid-lowering drugs can be broadly divided into drugs to promote uric acid excretion, inhibit uric acid synthesis drugs and new uric acid-lowering drugs. The representative drugs for promoting uric acid excretion are benzbromarone and probenecid, and the representative drugs for promoting uric acid excretion are benzbromarone and probenecid. Inhibition of uric acid synthesis drug representative drugs for allopurinol and febuxostat, through the inhibition of xanthine oxidase, so that the production of uric acid is reduced. Newer uric acid-lowering drugs include uric acid oxidase such as Labrylase, which can break down uric acid into soluble products for excretion. According to the patient’s condition and personal constitution and other factors to develop a specific drug treatment program, the need to exclude drug contraindications before the administration of drugs, the use of the above uric acid-lowering drugs for the treatment of the need to regularly to the hospital to review the blood uric acid, urinary uric acid, and other physical health indicators. Drugs need to be used under the guidance of a physician, it is recommended that patients to the relevant departments of the regular hospital for detailed consultation, standardize the use of medication, to avoid taking on their own.